News
Press Releases & Firm Announcements
Sheridan Capital Partners Closes Oversubscribed Fund IV at $1.1 Billion of Institutional Capital, Hitting Hard Cap

CHICAGO, IL – October 7, 2026 – (“Sheridan” or “SCP”) today announced the successful closing of Sheridan Capital Partners Fund IV (“Fund IV”) at its hard cap with $1.1 billion of total institutional capital commitments.

In the News
Behind the Deal: A Look into Sheridan Capital Partners’ Acquisition of Carolina Components Group

Sheridan Capital Partners discusses its acquisition of Carolina Components Group and the trends shaping biopharma M&A.

Press Releases & Firm Announcements
Sheridan Capital Partners Completes Investment in PtEverywhere

CHICAGO, IL – September 17, 2026 – Sheridan Capital Partners (“Sheridan” or “the Firm”) today announced the completion of its investment in PtEverywhere (“PtE” or “the Company”), a practice management and integrated payments software platform serving outpatient physical therapy and related rehabilitation providers. Terms of the private transaction were not disclosed.

Press Releases & Firm Announcements
Cadara Appoints Marina Aslanyan as Chief Executive Officer

TOMS RIVER, NJ – August 25, 2026 – Cadara™, formerly National Care Systems, today announced the appointment of Marina Aslanyan as Chief Executive Officer. She joins Cadara as the company continues expanding its technology platform and executing its long-term strategic vision.

Press Releases & Firm Announcements
Sheridan Capital’s Currier Plastics Acquires Sage Product Development

CHICAGO, IL – August 7, 2026 – Sheridan Capital Partners (“Sheridan”) today announced that its portfolio company, Currier Plastics (“Currier”), has completed the strategic acquisition of Sage Product Development (“Sage”), an engineering, design and development provider that helps its medical device customers take their products from concept to commercialization.

Press Releases & Firm Announcements
Sheridan Capital Partners Completes Investment in Carolina Components Group, a Key Supplier to Biopharmaceutical Manufacturers

CHICAGO, IL – August 4, 2026 – Sheridan Capital Partners (“Sheridan”) today announced the completion of its investment in Carolina Components Group (“CCG” or the “Company”), a provider of custom-engineered bioprocessing assemblies and components used in the manufacturing of biopharmaceuticals.

Press Releases & Firm Announcements
Tres Health Appoints Garry Welsh as New Board Member

BOCA RATON, FL – July 23, 2026 - Tres Health, a national alternative health insurance and technology company, today announced the appointment of Garry Welsh to Tres Health’s Board of Directors.

Press Releases & Firm Announcements
Sheridan Capital Partners Completes Investment in National Alternative Health Insurance Technology Company Tres Health

CHICAGO, IL – June 3, 2026 – Sheridan Capital Partners (“Sheridan”) today announced the completion of its investment in Tres Health, Inc. (“Tres” or the “Company”), a national alternative health insurance and technology company. Financial terms of the private transaction were not disclosed.